1
The H and 13C NMR spectra were taken on a Bruker DRX-400 spectrometer at 400 and 100 MHz,
respectively, in DMSO-d6 with TMS as the internal standard. The mass spectra were taken on a Varian
MAT 311A mass spectrometer with direct sample inlet into the source, accelerating voltage 3 kV, and ionizing
electron energy 70 eV.
Synthesis of Alkylsulfanylpyrrolidinium Salts 3a-c (General Method). Alkyl bromide (8.0 mmol) is
added to a solution of hydrazone 1 (0.5 g, 1.6 mmol) in acetone (5 ml). The reaction mixture is maintained for
24 h at room temperature. Then, ether is added. The precipitate is filtered off and washed with ether.
1-[1-Benzylsulfanyl-2-phenyl-2-(2-phenylhydrazono)ethylidene]pyrrolidinium Bromide (3b) was
1
obtained in 97% yield; mp 140-141°C. H NMR spectrum, , ppm (J, Hz): 2.02-2.11 (2H, m, CH2); 2.18-2.28
(2H, m, CH2); 3.64-3.76 (2H, m, NCH2); 4.05-4.11 (2H, m, NCH2); 4.05 and 4.25 (2H, AB system, J = 14.0,
SCH2); 6.96-7.02 (1H, m, C6H5); 7.09-7.16 (5H, m, C6H5); 7.31-7.36 (4H, m, C6H5); 7.43-7.53 (3H, m, C6H5);
7.72 (2H, d, J = 6.8, C6H5); 10.62 (1H, s, NH). Mass spectrum, m/z (Irel, %): 309 [M-C7H7Br]+ (12). Found, %:
C 62.32; H 5.37; N 8.66. C25H26BrN3S. Calculated, %: C 62.50; H 5.42; N 8.75.
1-[1-Allylsulfanyl-2-phenyl-2-(2-phenylhydrazono)ethylidene]pyrrolidinium Bromide (3b) was
obtained in 87% yield; mp 143-144°C. 1H NMR spectrum, , ppm (J, Hz): 2.00-2.46 (4H, m, CH2); 3.63 (2H, d,
J = 6.9, SCH2); 3.65-3.98 (2H, m, NCH2); 3.98-4.20 (1H, m, NCH2); 4.24-4.45 (1H, m, NCH2); 5.05 (1H, d,
J = 10.4, CH2 allyl); 5.19 (1H, d, J = 16.8, CH2 allyl); 5.52-5.81 (1H, m, CH allyl); 6.93 (1H, t, J = 6.8, C6H5);
7.27 (2H, d, J = 7.8, C6H5); 7.33-7.50 (3H, m, C6H5); 7.59 (2H, d, J = 7.8, C6H5); 7.71 (2H, d, J = 8.2, C6H5);
11.09 (1H, s, NH). Mass spectrum, m/z (Irel, %): 309 [M-C2H5Br]+ (21). Found, %: C 58.54; H 5.51; N 9.67.
C21H24BrN3S. Calculated, %: C 58.60; H 5.58; N 9.77.
1-[1-(Prop-2-inylsulfanyl)-2-phenyl-2-(2-phenylhydrazono)ethylidene]pyrrolidinium Bromide (3c)
1
was obtained in 89% yield; mp 150-151°C. H NMR spectrum, , ppm (J, Hz): 2.02-2.39 (4H, m, CH2); 2.92
(1H, t, J = 2.4, CH); 3.65-3.93 (2H, m, NCH2); 3.78 and 3.81 (2H, AB system, J = 17.0, SCH2); 4.00-4.20 (1H,
m, NCH2); 4.21-4.40 (1H, m, NCH2); 6.95 (1H, t, J = 7.5, C6H5); 7.29 (2H, t, J = 7.6, C6H5); 7.38-7.51 (5H, m,
C6H5); 7.72 (2H, d, J = 8.4, C6H5); 11.08 (1H, s, NH). Mass spectrum, m/z (Irel, %): 309 [M-C3H3Br]+ (18).
Found, %: C 58.81; H 4.98; N 9.50. C21H22BrN3S. Calculated, %: C 58.88; H 5.14; N 9.81.
Intramolecular Cyclization of 1-[1-Alkylsulfanyl-2-phenyl-2-(phenylhydrazono)ethylidene]pyrrolidi-
nium Bromides 3a-c (General Method). The Cs2CO3 (0.15 g, 0.47 mmol) was added to a solution of pyrrolidinium
salt 3a-c (0.47 mmol) in DMF (5 ml). The reaction mixture was stirred until the starting reagent disappeared as
indicated by thin-layer chromatography. The solvent was evaporated in vacuum. Pyrrolotriazine 4 was separated on
a column packed with KSK silica gel (40-100 m) using 4:1 hexane–ethyl acetate as the eluent.
1,3-Diphenyl-6,7,8,8a-tetrahydro-1H-pyrrolo[2,1-c]-1,2,4-triazine-4-thione (4), mp 110-111°C.
1H NMR spectrum, , ppm (J, Hz): 1.94-2.17 (3H, m, CH2); 2.61-2.70 (1H, m, CH2); 3.80-3.98 (2H, m, CH2);
5.10 (1H, dd, J = 5.8, J = 7.6, H-8a); 7.25-7.38 (4H, m, C6H5); 7.39-7.47 (4H, m, C6H5); 7.65 (1H, dd, J = 8.0,
J = 2.0, C6H5). 13C NMR spectrum, , ppm: 21.0 (CH2), 32.1 (CH2), 51.5 (CH2), 71.7 (C(8a)H), 123.2, 126.1,
127.3, 127.9, 128.8, 129.0, 135.3, 144.3, 145.6, 175.8 (CS). Mass spectrum, m/z (Irel, %): 307 [M]+ (2). Found,
%: C 70.12; H 5.29; N 10.59. C18H17N3S. Calculated, %: C 70.33; H 5.57; N 10.43.
This work was carried out with the financial support of the Russian Basic Research Fund
(Grants 08-03-00376_a, 08-03-92208 GFEN (Natural Sciences State Fund)_a, 10-03-96084-r-ural_a).
REFERENCES
1.
2.
N. P. Belskaia, T. G. Deryabina, A. V. Koksharov, M. I. Kodess, W. Dehaen, A. T. Lebedev, and
V. A. Bakulev, Tetrahedron Lett., 48, 9128 (2007).
J. L. Hunt, T. Mitt, R. Borzilleri, J. Gullo-Brown, J. Fargnolli, B. Fink, W.-C. Han, S. Mortillo, G. Vite,
B. Wautlet, T. Wong, X. Zheng, and R. Bhide, J. Med. Chem., 47, 4054 (2004).
1157